Exploring the science of psychelics

In this article by Tom Angell, he outlines the current legal status of marijuana in the United States. He states that 33 states have legalized it for medical purposes and additional 10 have legalized the pant for recreational use. The author also goes over which states are likely to change their laws regarding marijuana soon.  Although never explicitly stated, it seems as though the article has a pro-legalization view. The article is fairly short and to the point in delivering the information. Several reputable sources and direct quotes from elected officials are in the article. This adds to the author's credibility.  Angell, Tom. “These States Are Most Likely To Legalize Marijuana In 2019.” Forbes, Forbes Magazine, 31 Dec. 2018, www.forbes.com/sites/tomangell/2018/12/26/these-states-are-most-likely-to-legalize-marijuana-in-2019/#7097dc635add.

The sources cited on this slide are journal articles publishing the results from their studies regarding psychedelics. There isn't really an argument in them as they are simply stating their results.  Roseman, Leor, et al. “Increased Amygdala Responses to Emotional Faces after Psilocybin for Treatment-Resistant Depression.” Neuropharmacology , vol. 142, Nov. 2018, pp. 263–269. EBSCOhost , doi:10.1016/j.neuropharm.2017.12.041. Watts, Rosalind, et al. “Patients’ Accounts of Increased ‘Connectedness’ and ‘Acceptance’ After Psilocybin for Treatment-Resistant Depression.” Journal of Humanistic Psychology, vol. 57, no. 5, Sept. 2017, pp. 520–564. EBSCOhost, doi:10.1177/0022167817709585.

I am going to take an argumentative approach to my paper. I plan on exploring the research around psychedelics and then argue that there should be a broader discussion happening regarding psychedelics and their therapeutic use and what legalization should look like, based on research.